Screener
NeoGenomics NEO EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from NeoGenomics’s reported figures.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
FAQ
- What is NeoGenomics's EBITDA?
- NeoGenomics (NEO) reported EBITDA of $3.42M in Q2 2026.
- How has NeoGenomics's EBITDA changed year-over-year?
- NeoGenomics's EBITDA increased by 111.3% year-over-year, from -$30.36M to $3.42M.
- What is the long-term trend for NeoGenomics's EBITDA?
- Over 4 years (2021 to 2025), NeoGenomics's EBITDA has grown at a -7.4% compound annual growth rate (CAGR), from -$65.4M to -$48.06M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about NeoGenomics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude